Skip to content
PeptideAgent

Are peptides legal in North Dakota?

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The short answer

Yes. A North Dakota resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a North Dakota-licensed prescriber, including by telemedicine under NDCC 43-17-44, which requires a bona fide relationship, identity verification, and the same standard of care as in-person practice. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy holding a North Dakota State Board of Pharmacy permit. North Dakota is unusual in two ways: every out-of-state pharmacy shipping prescriptions into the state must hold a full North Dakota pharmacy permit, and in-state pharmacies must be majority owned by pharmacists under NDCC 43-15-35.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Sep 22, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a North Dakota resident get peptides by telehealth?

NDCC 43-17-44 requires a physician or physician assistant practicing telemedicine to establish a bona fide relationship with the patient before diagnosis or treatment, verify the patient's identity, disclose their own identity and licensure, and meet the same standard of care and ethics as in-person practice. The Board of Medicine's telemedicine rules in NDAC chapter 50-02-15 implement the statute, and prescribing controlled substances over the internet requires a valid prescription. The prescriber must hold a North Dakota license. Neither source confirmed for this draft addresses whether a questionnaire-only asynchronous encounter can create the bona fide relationship, so asynchronous prescribing is left unconfirmed. None of the peptides in this database are controlled substances. [2] [3]

How does the North Dakota pharmacy board treat compounding?

Compounding regulator for North Dakota
BoardNorth Dakota State Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The North Dakota State Board of Pharmacy licenses pharmacists and permits pharmacies under NDCC chapter 43-15 and adopts rules in NDAC Title 61. Under NDAC chapter 61-08-01, any pharmacy that ships, mails, or delivers prescription drugs into North Dakota must obtain and hold a North Dakota pharmacy permit and follow North Dakota law for the part of its operation that dispenses to North Dakota residents; permits are renewed each year by July 1. NDCC 43-15-35 requires in-state pharmacies to be majority owned by North Dakota-licensed pharmacists, a rule upheld by the U.S. Supreme Court in North Dakota State Board of Pharmacy v. Snyder's Drug Stores (1973). Compounding standards are in NDAC chapter 61-02-01 (pharmacy permits): section 61-02-01-03 requires nonsterile compounding to meet USP chapter 795 and sterile preparations to be compounded, and sterile compounding facilities and equipment to conform, according to USP chapter 797, with hazardous drugs handled under USP chapter 800, and the chapter issues a separate Class C permit to pharmacies that dispense sterile injectable products to the general public. North Dakota has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [4] [5] [6] [8]

Can you get compounded GLP-1s in North Dakota?

Regulatory: Compounded GLP-1 limited

Because North Dakota requires a full pharmacy permit for every out-of-state shipper, fewer national telehealth pharmacies serve the state, and patients should confirm the pharmacy's North Dakota permit before ordering. [4] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in North Dakota?

Verified access options

Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.

Find a provider in North Dakota

Is it legal to buy research peptides in North Dakota?

The North Dakota Food, Drug, and Cosmetic Act (NDCC chapter 19-02.1) prohibits selling adulterated or misbranded drugs, and NDCC chapter 43-15 limits dispensing of prescription drugs to permitted pharmacies and licensed practitioners. [6] [7] [12]

Peptide-specific notes for North Dakota

Peptide-specific notes for North Dakota
PeptideNote
SemaglutideAvailable branded by prescription, including by telemedicine from a North Dakota-licensed prescriber who has established a bona fide relationship under NDCC 43-17-44. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [11]

Frequently asked questions

Can I get a GLP-1 prescription in North Dakota through telemedicine?

Yes, from a North Dakota-licensed prescriber who establishes a bona fide relationship, verifies your identity, and meets the in-person standard of care under NDCC 43-17-44. Semaglutide and tirzepatide are not controlled substances. [2]

Can an out-of-state pharmacy ship compounded peptides to me in North Dakota?

Only if it holds a North Dakota pharmacy permit issued by the State Board of Pharmacy. North Dakota requires every pharmacy that ships prescription drugs into the state to hold a permit and follow North Dakota rules for that dispensing. [1] [4]

Why are most North Dakota pharmacies independently owned?

NDCC 43-15-35 requires in-state pharmacies to be majority owned by North Dakota-licensed pharmacists. The U.S. Supreme Court upheld the law in 1973, and it continues to limit chain pharmacy ownership in the state. [6]

Can a North Dakota pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.

  1. [1]North Dakota State Board of Pharmacy
  2. [2]NDCC 43-17-44, Telemedicine (in chapter 43-17, Physicians and physician assistants)
  3. [3]NDAC chapter 50-02-15, Telemedicine (North Dakota Board of Medicine)
  4. [4]NDAC chapter 61-08-01, Requirements for out-of-state pharmacies
  5. [5]NDAC chapter 61-02-01, Pharmacy permits (section 61-02-01-03, pharmaceutical compounding standards)
  6. [6]NDCC chapter 43-15, Pharmacy (including 43-15-35, pharmacist ownership)
  7. [7]NDCC chapter 19-02.1, Food, Drug, and Cosmetic Act
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, September 22). Are peptides legal in North Dakota?. https://peptideagent.ai/legal/north-dakota
HTML link
<a href="https://peptideagent.ai/legal/north-dakota">Are peptides legal in North Dakota?</a>, PeptideAgent, updated September 22, 2026.